CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Exicure, Inc. - XCUR CFD

0.93
1.06%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.94
Open* 0.92
1-Year Change* 384.21%
Day's Range* 0.87 - 0.93
52 wk Range 0.63-10.16
Average Volume (10 days) 11.26K
Average Volume (3 months) 4.73M
Market Cap 4.85M
P/E Ratio -100.00K
Shares Outstanding 4.96M
Revenue 9.17M
EPS -9.35
Dividend (Yield %) N/A
Beta 1.01
Next Earnings Date Mar 23, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 22, 2023 0.93 0.01 1.09% 0.92 0.94 0.87
Mar 21, 2023 0.94 0.01 1.08% 0.93 0.96 0.93
Mar 20, 2023 0.94 -0.01 -1.05% 0.95 0.97 0.94
Mar 17, 2023 0.98 -0.05 -4.85% 1.03 1.03 0.96
Mar 16, 2023 0.95 -0.07 -6.86% 1.02 1.02 0.95
Mar 15, 2023 1.02 -0.01 -0.97% 1.03 1.03 1.00
Mar 14, 2023 1.04 0.03 2.97% 1.01 1.06 0.99
Mar 13, 2023 1.04 0.01 0.97% 1.03 1.04 0.99
Mar 10, 2023 1.03 -0.08 -7.21% 1.11 1.11 0.99
Mar 9, 2023 1.12 -0.04 -3.45% 1.16 1.16 1.10
Mar 8, 2023 1.09 -0.04 -3.54% 1.13 1.13 1.08
Mar 7, 2023 1.12 -0.01 -0.88% 1.13 1.15 1.12
Mar 6, 2023 1.14 0.00 0.00% 1.14 1.15 1.12
Mar 3, 2023 1.13 0.06 5.61% 1.07 1.14 1.07
Mar 2, 2023 1.09 0.00 0.00% 1.09 1.13 1.07
Mar 1, 2023 1.11 0.02 1.83% 1.09 1.11 1.07
Feb 28, 2023 1.13 -0.04 -3.42% 1.17 1.20 1.08
Feb 27, 2023 1.20 0.00 0.00% 1.20 1.22 1.18
Feb 24, 2023 1.12 -0.04 -3.45% 1.16 1.16 1.10
Feb 23, 2023 1.14 -0.02 -1.72% 1.16 1.21 1.14

Exicure, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue -0.483 16.613 1.296 0.118 9.719
Revenue -0.483 16.613 1.296 0.118 9.719
Total Operating Expense 62.066 42.049 27.913 21.937 21.154
Selling/General/Admin. Expenses, Total 13.087 9.955 8.573 7.818 7.046
Research & Development 48.979 32.094 19.34 14.119 14.108
Operating Income -62.549 -25.436 -26.617 -21.819 -11.435
Interest Income (Expense), Net Non-Operating -1.542 0.446 -0.065 -0.672 -0.795
Other, Net -0.011 0.322 0.379 0.078 0.191
Net Income Before Taxes -64.102 -24.668 -26.303 -22.413 -12.039
Net Income After Taxes -64.102 -24.668 -26.303 -22.413 -12.039
Net Income Before Extra. Items -64.102 -24.668 -26.303 -22.413 -12.039
Net Income -64.102 -24.668 -26.303 -22.413 -12.039
Income Available to Common Excl. Extra. Items -64.102 -24.668 -26.303 -22.413 -12.039
Income Available to Common Incl. Extra. Items -64.102 -24.668 -26.303 -22.413 -12.039
Diluted Net Income -64.102 -24.668 -26.303 -22.413 -12.039
Diluted Weighted Average Shares 2.95362 2.9065 1.9222 1.37284 1.3099
Diluted EPS Excluding Extraordinary Items -21.7029 -8.4872 -13.6838 -16.3261 -9.1908
Diluted Normalized EPS -21.7029 -8.4872 -13.6838 -16.3261 -9.1908
Total Extraordinary Items 0 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 2.565 2.118 -3.677 0.079 0.997
Revenue 2.565 2.118 -3.677 0.079 0.997
Total Operating Expense 10.302 15.567 19.404 13.941 13.154
Selling/General/Admin. Expenses, Total 3.162 4.15 2.947 3.098 2.892
Research & Development 7.14 11.417 16.457 10.843 10.262
Operating Income -7.737 -13.449 -23.081 -13.862 -12.157
Interest Income (Expense), Net Non-Operating -0.591 -0.372 -0.445 -0.405 -0.32
Other, Net -0.02 -0.004 -0.005 -0.002 0
Net Income Before Taxes -8.348 -13.825 -23.531 -14.269 -12.477
Net Income After Taxes -8.348 -13.825 -23.531 -14.269 -12.477
Net Income Before Extra. Items -8.348 -13.825 -23.531 -14.269 -12.477
Net Income -8.348 -13.825 -23.531 -14.269 -12.477
Income Available to Common Excl. Extra. Items -8.348 -13.825 -23.531 -14.269 -12.477
Income Available to Common Incl. Extra. Items -8.348 -13.825 -23.531 -14.269 -12.477
Diluted Net Income -8.348 -13.825 -23.531 -14.269 -12.477
Diluted Weighted Average Shares 4.03093 3.01522 2.93654 2.93449 2.92812
Diluted EPS Excluding Extraordinary Items -2.07099 -4.58507 -8.01317 -4.86252 -4.2611
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -2.07099 -4.58507 -8.01317 -4.86252 -4.2611
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 43.666 86.322 112.776 27.663 27.638
Cash and Short Term Investments 39.141 82.08 110.786 26.268 25.764
Cash & Equivalents 34.644 33.262 48.46 26.268 25.764
Total Receivables, Net 0 0.011 0.271 0.013 0.03
Accounts Receivable - Trade, Net 0 0.011 0.035 0.003 0.013
Prepaid Expenses 3.247 4.231 1.014 1.382 1.844
Total Assets 64.868 100.444 115.263 28.756 28.987
Property/Plant/Equipment, Total - Net 11.877 12.729 2.455 1.061 1.317
Property/Plant/Equipment, Total - Gross 14.544 14.469 3.772 2.25 2.166
Accumulated Depreciation, Total -2.667 -1.74 -1.317 -1.189 -0.849
Other Long Term Assets, Total 9.325 1.393 0.032 0.032 0.032
Total Current Liabilities 34.067 13.734 31.087 2.043 3.356
Accounts Payable 3.413 1.866 1.814 0.5 1.049
Accrued Expenses 6.464 3.525 2.435 1.543 1.273
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6.873 0 4.965 0
Other Current Liabilities, Total 17.317 8.343 21.873 0 1.034
Total Liabilities 53.636 38.938 34.516 7.804 9.012
Total Long Term Debt 0 16.589 0 4.925 4.855
Long Term Debt 0 16.589 0 4.925 4.855
Other Liabilities, Total 19.569 8.615 3.429 0.836 0.801
Total Equity 11.232 61.506 80.747 20.952 19.975
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 0.011 0.009 0.009 0.004 0.004
Additional Paid-In Capital 181.29 167.379 162.062 75.942 53.586
Retained Earnings (Accumulated Deficit) -170.067 -105.965 -81.297 -54.994 -33.615
Total Liabilities & Shareholders’ Equity 64.868 100.444 115.263 28.756 28.987
Total Common Shares Outstanding 3.62574 2.92142 2.86869 1.47845 1.3099
Short Term Investments 4.497 48.818 62.326
Other Current Assets, Total 1.278 0.705
Other Equity, Total -0.002 0.083 -0.027
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 29.182 43.666 64.147 60.647 73.987
Cash and Short Term Investments 26.384 39.141 60.838 56.059 67.436
Cash & Equivalents 23.89 34.644 51.885 42.587 34.296
Short Term Investments 2.494 4.497 8.953 13.472 33.14
Total Receivables, Net 0 0.027 0.044 0.224
Accounts Receivable - Trade, Net 0 0 0 0
Prepaid Expenses 1.669 3.247 2.173 3.642 5.02
Other Current Assets, Total 1.129 1.278 1.109 0.902 1.307
Total Assets 41.896 64.868 77.9 74.467 87.948
Property/Plant/Equipment, Total - Net 11.393 11.877 12.288 12.383 12.535
Property/Plant/Equipment, Total - Gross 14.359 14.544 14.661 14.473 14.346
Accumulated Depreciation, Total -2.966 -2.667 -2.373 -2.09 -1.811
Other Long Term Assets, Total 1.321 9.325 1.465 1.437 1.426
Total Current Liabilities 21.361 34.067 21.98 12.745 12.763
Accounts Payable 1.918 3.413 2.485 2.25 2.976
Accrued Expenses 3.227 6.464 5.48 3.228 2.441
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 16.216 17.317 14.015 7.267 7.346
Total Liabilities 38.66 53.636 63.917 37.827 37.907
Total Long Term Debt 0 0 16.801 16.73 16.659
Long Term Debt 0 16.801 16.73 16.659
Other Liabilities, Total 17.299 19.569 25.136 8.352 8.485
Total Equity 3.236 11.232 13.983 36.64 50.041
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.012 0.011 0.009 0.009 0.009
Additional Paid-In Capital 181.644 181.29 170.217 169.337 168.442
Retained Earnings (Accumulated Deficit) -178.415 -170.067 -156.242 -132.711 -118.442
Other Equity, Total -0.005 -0.002 -0.001 0.005 0.032
Total Liabilities & Shareholders’ Equity 41.896 64.868 77.9 74.467 87.948
Total Common Shares Outstanding 4.0931 3.62574 2.93666 2.93626 2.93283
Current Port. of LT Debt/Capital Leases 0 6.873
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -64.102 -24.668 -26.303 -22.413 -12.039
Cash From Operating Activities -34.819 -39.27 1.317 -19.487 -19.789
Cash From Operating Activities 1.123 0.766 0.392 0.358 0.232
Non-Cash Items 4.048 2.896 1.981 2.179 1.437
Changes in Working Capital 24.112 -18.264 25.247 0.389 -9.419
Cash From Investing Activities 43.085 10.142 -63.432 -0.094 -0.926
Capital Expenditures -0.968 -3.171 -1.082 -0.094 -0.926
Cash From Financing Activities 1.116 15.13 84.307 20.085 26.856
Financing Cash Flow Items -1.125 -0.711 -6.518 -1.957 -3.699
Issuance (Retirement) of Stock, Net 12.241 3.34 90.825 22.042 31.556
Issuance (Retirement) of Debt, Net -10 12.501 0 -1.001
Net Change in Cash 9.382 -13.998 22.192 0.504 6.141
Other Investing Cash Flow Items, Total 44.053 13.313 -62.35
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -8.348 -64.102 -50.277 -26.746 -12.477
Cash From Operating Activities -12.756 -34.819 -21.022 -25.885 -14.809
Cash From Operating Activities 0.302 1.123 0.829 0.546 0.263
Non-Cash Items 1.006 4.048 3.04 1.578 0.693
Changes in Working Capital -5.716 24.112 25.386 -1.263 -3.288
Cash From Investing Activities 1.995 43.085 38.977 34.533 15.297
Capital Expenditures -0.006 -0.968 -0.623 -0.564 -0.225
Other Investing Cash Flow Items, Total 2.001 44.053 39.6 35.097 15.522
Cash From Financing Activities -7.993 1.116 0.668 0.677 0.546
Financing Cash Flow Items -0.507 -1.125 -0.009 0 0
Issuance (Retirement) of Stock, Net 0.014 12.241 0.677 0.677 0.546
Issuance (Retirement) of Debt, Net -7.5 -10 0 0 0
Net Change in Cash -18.754 9.382 18.623 9.325 1.034

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

500K+

Traders

92K+

Active clients monthly

$53M+

Monthly investing volume

$30M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Exicure, Inc. Company profile

About Exicure Inc

Exicure, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutics for neurology, immuno-oncology, inflammatory diseases and other genetic disorders based on its spherical nucleic acid (SNA) technology. The Company develops XCUR-FXN, which is a spherical nucleic acid (SNA) -based therapeutic candidate for the treatment of Friedreich’s ataxia (FA). XCUR-FXN through its SNA technology incorporates more than one active oligonucleotides in a single SNA molecule. The Company’s therapeutic candidate cavrotolimod (AST-008) is a toll-like receptor 9 (TLR9) agonist designed for immuno-oncology applications utilizing its SNA technology. AST-008 is in a Phase I b/II clinical trial in patients with advanced solid tumors. TLR9 agonists binds to and activate TLR9.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Exicure Inc revenues decreased from $16.5M to -$2.6M. Net loss increased from $12M to $50.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development expense - Balan increase of 69% to $36.5M (expense), General and administrative expense - Bal increase of 25% to $7.8M (expense).

Industry: Bio Therapeutic Drugs

2430 N. Halsted St.
CHICAGO
ILLINOIS 60614
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

27,457.10 Price
-2.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

XRP/USD

0.43 Price
-13.610% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00346

Gold

1,974.70 Price
+1.750% 1D Chg, %
Long position overnight fee -0.0086%
Short position overnight fee 0.0004%
Overnight fee time 21:00 (UTC)
Spread 0.30

Oil - Crude

70.18 Price
+0.950% 1D Chg, %
Long position overnight fee -0.0170%
Short position overnight fee -0.0050%
Overnight fee time 21:00 (UTC)
Spread 0.03

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading